During the recent session, Dogwood Therapeutics Inc (NASDAQ:DWTX)’s traded shares were 2.05 million, with the beta value of the company hitting 2.11. At the last check today, the stock’s price was $6.42, reflecting an intraday gain of 45.00% or $1.99. The 52-week high for the DWTX share is $29.28, that puts it down -356.07 from that peak though still a striking 74.77% gain since the share price plummeted to a 52-week low of $1.62. The company’s market capitalization is $8.55M, and the average trade volume was 2.71 million shares over the past three months.

Dogwood Therapeutics Inc (NASDAQ:DWTX) trade information

Dogwood Therapeutics Inc (DWTX) registered a 45.00% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 45.00% in intraday trading to $6.42, hitting a weekly high. The stock’s 5-day price performance is 34.10%, and it has moved by -47.82% in 30 days. Based on these gigs, the overall price performance for the year is -22.61%.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -2.02%. While earnings are projected to return 13.86% in 2025, the next five years will return 5.11% per annum.

DWTX Dividends

Dogwood Therapeutics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Dogwood Therapeutics Inc (NASDAQ:DWTX)’s Major holders

Also, the Mutual Funds coming in first place with the largest holdings of Dogwood Therapeutics Inc (DWTX) shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. Data provided on Sep 30, 2024 indicates that Vanguard Extended Market Index Fund owns about 16.71 shares. This amounts to just over 1.25 percent of the company’s overall shares, with a $98427.0 market value. The same data shows that the other fund manager holds slightly less at 5.86, or about 0.44% of the stock, which is worth about $34491.0.